Advertisement

2016 Spring CLU Highlights

PCSK9 Inhibitors: Practical Aspects of their use in Patients with Familial Hypercholesterolemia

Dr. James A. Underberg

James A. Underberg, MD, MS, FACPM, FACP, FASH, FNLA

Dr. James A. Underberg presents his talk at the 2015 Fall Clinical Lipid Update on PCSK9 Inhibitors: Practical Aspects of their use in Patients with Familial Hypercholesterolemia  

Start Presentation Slides Audio Only

Tags:


Key Clinical Lipidology Publications: 2015-16

Dr. Kevin C. Maki

Kevin C. Maki, PhD, CLS, FNLA, FTOS, FACN

Dr. Kevin C. Maki presents his talk at the 2015 Fall Clinical Lipid Update on Key Clinical Lipidology Publications: 2015-16

Start Presentation Slides Audio Only

Tags:


Should PCSK9 Inhibitors be Used in Statin Intolerant Patients?

Dr. Terry A. Jacobson

Terry A. Jacobson MD FACP FNLA

Dr. Terry A. Jacobson presents his talk at the 2015 Fall Clinical Lipid Update on Should PCSK9 Inhibitors be Used in Statin Intolerant Patients?

Start Presentation Slides Audio Only

Tags:


PCSK9 Inhibitors: Impact on the Management of LDL Apheresis Candidates and LDL Apheresis Patients

Dr. Anne Carol Goldberg

Anne Carol Goldberg, MD, FNLA

Dr. Anne Carol Goldberg presents her talk at the 2015 Fall Clinical Lipid Update on PCSK9 Inhibitors: Impact on the Management of LDL Apheresis Candidates and LDL Apheresis Patients 

Start Presentation Slides Audio Only

Tags:


Copyright © 2018 National Lipid Association. All Rights Reserved.

Privacy Policy Terms of Service